These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27842519)

  • 21. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients.
    Alberts JL; Voelcker-Rehage C; Hallahan K; Vitek M; Bamzai R; Vitek JL
    Brain; 2008 Dec; 131(Pt 12):3348-60. PubMed ID: 18842609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.
    Okun MS; Gallo BV; Mandybur G; Jagid J; Foote KD; Revilla FJ; Alterman R; Jankovic J; Simpson R; Junn F; Verhagen L; Arle JE; Ford B; Goodman RR; Stewart RM; Horn S; Baltuch GH; Kopell BH; Marshall F; Peichel D; Pahwa R; Lyons KE; Tröster AI; Vitek JL; Tagliati M;
    Lancet Neurol; 2012 Feb; 11(2):140-9. PubMed ID: 22239915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of STN-DBS on mood, drive, anhedonia and risk of psychiatric side-effects in the population of PD patients.
    Antosik-Wójcińska A; Święcicki Ł; Dominiak M; Sołtan E; Bieńkowski P; Mandat T
    J Neurol Sci; 2017 Apr; 375():342-347. PubMed ID: 28320164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ECT for Parkinson's disease.
    Popeo D; Kellner CH
    Med Hypotheses; 2009 Oct; 73(4):468-9. PubMed ID: 19660875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations.
    Borisovskaya A; Bryson WC; Buchholz J; Samii A; Borson S
    Neurodegener Dis Manag; 2016 Apr; 6(2):161-76. PubMed ID: 27033556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease.
    Aono M; Iga J; Ueno S; Agawa M; Tsuda T; Ohmori T
    J Clin Neurosci; 2014 Sep; 21(9):1595-8. PubMed ID: 24794694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mental Health-Related Healthcare Use Following Bilateral Deep Brain Stimulation For Parkinson's Disease.
    Westbay LC; Cao L; Burnett-Zeigler I; Reizine N; Barton B; Ippolito D; Weaver FM; Stroupe KT
    J Parkinsons Dis; 2015; 5(3):497-504. PubMed ID: 26406129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electroconvulsive therapy in Parkinson's disease.
    Calderón-Fajardo H; Cervantes-Arriaga A; Llorens-Arenas R; Ramírez-Bermudez J; Ruiz-Chow Á; Rodríguez-Violante M
    Arq Neuropsiquiatr; 2015 Oct; 73(10):856-60. PubMed ID: 26331387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reward circuit DBS improves Parkinson's gait along with severe depression and OCD.
    Williams NR; Hopkins TR; Short EB; Sahlem GL; Snipes J; Revuelta GJ; George MS; Takacs I
    Neurocase; 2016; 22(2):201-4. PubMed ID: 26644268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Boel JA; Odekerken VJ; Schmand BA; Geurtsen GJ; Cath DC; Figee M; van den Munckhof P; de Haan RJ; Schuurman PR; de Bie RM;
    Parkinsonism Relat Disord; 2016 Dec; 33():90-95. PubMed ID: 27688200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of subthalamic stimulation on mood state in Parkinson's disease: evaluation of previous facts and problems.
    Takeshita S; Kurisu K; Trop L; Arita K; Akimitsu T; Verhoeff NP
    Neurosurg Rev; 2005 Jul; 28(3):179-86; discussion 187. PubMed ID: 15827764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of mood disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation].
    Maes H; Vingerhoets F; Berney A
    Rev Med Suisse; 2011 Feb; 7(282):385-8. PubMed ID: 21416865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromodulation in obsessive-compulsive disorder.
    Bais M; Figee M; Denys D
    Psychiatr Clin North Am; 2014 Sep; 37(3):393-413. PubMed ID: 25150569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression and intelligence in patients with Parkinson's disease and deep-brain stimulation.
    Schadt CR; Cox KL; Tramontana MG; Byrne DW; Davis TL; Fang JY; Konrad PE; Padaliya B; Mutter RW; Gill CE; Richardson CR; Charles PD
    J Natl Med Assoc; 2006 Jul; 98(7):1121-5. PubMed ID: 16895282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?
    Rizzone MG; Fasano A; Daniele A; Zibetti M; Merola A; Rizzi L; Piano C; Piccininni C; Romito LM; Lopiano L; Albanese A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):376-81. PubMed ID: 24508574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.